menu
    • menu

    Company profile for Theradaptive

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Theradaptive is developing a therapeutic delivery platform for multiple clinical indications including immuno-oncology, orthopedics and soft tissue repair. Our computational platform converts recombinant proteins into material-binding variants that can be used to coat implants, devices, and injectable carriers. This novel and unprecedented method enables us to deliver therapeutics to any location in the body with precision.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TheradaptiveUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5350 Partners Ct suite B, Frederick, MD 21703
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.theradaptive.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/theradaptive/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theradaptive Complete Enrollment In Osteoadapt DE in Dental Study
    Theradaptive Complete Enrollment In Osteoadapt DE in Dental Study

    23 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theradaptive-announces-final-patient-enrolled-in-restore-feasibility-study-evaluating-osteoadapt-de-in-dental-procedures-302751818.html

    PR NEWSWIRE
    23 Apr 2026
    Share Share
    Theradaptive Treats First Patient in RESTORE Study for OsteoAdapt
    Theradaptive Treats First Patient in RESTORE Study for OsteoAdapt

    26 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theradaptive-treats-first-patient-in-restore-feasibility-study-evaluating-osteoadapt-de-in-dental-procedures-302538407.html

    PR NEWSWIRE
    26 Aug 2025
    Share Share
    Theradaptive Secures MSCRF Funding For Human Trials
    Theradaptive Secures MSCRF Funding For Human Trials

    22 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theradaptive-secures-landmark-funding-from-maryland-stem-cell-research-fund-mscrf-to-support-human-clinical-trials-302151884.html

    PR NEWSWIRE
    22 May 2024
    Share Share
    Theradaptive Awarded $4M DOD Contract for OsteoAdapt Regenerative Program
    Theradaptive Awarded $4M DOD Contract for OsteoAdapt Regenerative Program

    02 Mar 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-02/theradaptive-awarded-4m-dod-contract-for-osteoadapt-regenerative-therapeutic-program/?widget=listSection

    CONTRACT PHARMA
    02 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search